These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38436618)
1. Can cell-free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I-III a nonsmall cell lung cancer (NSCLC)? A pilot study. Saikia J; Malik PS; Kumar S; Jain D; Madan K; Bharati SJ; Deo S; Kumar S J Surg Oncol; 2024 Jun; 129(7):1224-1234. PubMed ID: 38436618 [TBL] [Abstract][Full Text] [Related]
2. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid. Tsutani Y; Yamashita Y; Misumi K; Ikeda T; Miyata Y; Okada M Eur J Cardiothorac Surg; 2012 Nov; 42(5):e96-101. PubMed ID: 22906597 [TBL] [Abstract][Full Text] [Related]
3. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer. Ai B; Liu H; Huang Y; Peng P Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821 [TBL] [Abstract][Full Text] [Related]
4. Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital. Ghosh M; Mukhopadhyay M; Das C; Chatterjee S; Naskar BG J Cancer Res Ther; 2021; 17(6):1389-1396. PubMed ID: 34916369 [TBL] [Abstract][Full Text] [Related]
5. Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer? Vicidomini G; Santini M; Fiorello A; Parascandolo V; Calabrò B; Pastore V Ann Thorac Surg; 2005 Jan; 79(1):254-7; discussion 254-7. PubMed ID: 15620952 [TBL] [Abstract][Full Text] [Related]
6. KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer. Mastoraki S; Balgkouranidou I; Tsaroucha E; Klinakis A; Georgoulias V; Lianidou E Mol Oncol; 2021 Sep; 15(9):2412-2422. PubMed ID: 33159839 [TBL] [Abstract][Full Text] [Related]
7. Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing. Yu Y; Qian J; Shen L; Ji W; Lu S Int J Med Sci; 2021; 18(6):1510-1518. PubMed ID: 33628109 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients. Zhou X; Li C; Zhang Z; Li DY; Du J; Ding P; Meng H; Xu H; Li R; Ho E; Zhang A; Okunieff P; Lu J; Sha MY Sci Rep; 2021 Apr; 11(1):7633. PubMed ID: 33828112 [TBL] [Abstract][Full Text] [Related]
9. Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology. Nakao M; Hoshi R; Ishikawa Y; Matsuura Y; Uehara H; Mun M; Nakagawa K; Okumura S Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):777-82. PubMed ID: 25762707 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of circulating cell-free DNA quantification and metabolic tumor burden in advanced non-small cell lung cancer. Hyun MH; Lee ES; Eo JS; Kim S; Kang EJ; Sung JS; Choi YJ; Park KH; Shin SW; Lee SY; Kim YH Lung Cancer; 2019 Aug; 134():158-166. PubMed ID: 31319975 [TBL] [Abstract][Full Text] [Related]
11. Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer. Ottestad AL; Dai HY; Halvorsen TO; Emdal EF; Wahl SGF; Grønberg BH Cancer Treat Res Commun; 2021; 29():100471. PubMed ID: 34607221 [TBL] [Abstract][Full Text] [Related]
12. Positive intraoperative pleural lavage cytology is a predictive marker of disease recurrence in stage I lung adenocarcinoma. Yanagawa N; Shiono S; Abiko M; Abe M; Watanabe K; Watanabe I; Uematsu M; Ogata SY; Sato T; Tamura G Interact Cardiovasc Thorac Surg; 2014 May; 18(5):621-5. PubMed ID: 24532312 [TBL] [Abstract][Full Text] [Related]
13. Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer. Lim E; Ali A; Theodorou P; Nicholson AG; Ladas G; Goldstraw P J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1113-8. PubMed ID: 15052210 [TBL] [Abstract][Full Text] [Related]
14. Clinical impact of intraoperative detection of carcinoembryonic antigen mRNA in pleural lavage specimens from nonsmall cell lung cancer patients. Satoh Y; Sugai S; Uehara H; Mun M; Sakao Y; Okumura S; Nakagawa K; Ishikawa Y; Miki Y; Miyata S Thorac Cardiovasc Surg; 2012 Dec; 60(8):533-40. PubMed ID: 22252332 [TBL] [Abstract][Full Text] [Related]
15. Plasma cfDNA as a potential treatment monitoring and prognostic index in patients withnon-small cell lung cancer. Chen N; Li G; Li H; Xiang X; Guo G; Ma Q; Zhang Y Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):208-213. PubMed ID: 33040838 [TBL] [Abstract][Full Text] [Related]
16. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy. Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of intraoperative pleural lavage cytology for non-small cell lung cancer: the influence of positive pleural lavage cytology results on T classification. Kameyama K; Okumura N; Miyaoka E; Asamura H; Yoshino I; Tada H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Kobayashi H; Sawabata N; Okumura M; Yokoi K; J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2659-64. PubMed ID: 25173121 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer. Balgkouranidou I; Chimonidou M; Milaki G; Tsarouxa EG; Kakolyris S; Welch DR; Georgoulias V; Lianidou ES Br J Cancer; 2014 Apr; 110(8):2054-62. PubMed ID: 24642624 [TBL] [Abstract][Full Text] [Related]
19. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer. Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591 [TBL] [Abstract][Full Text] [Related]